Navigation Links
Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
Date:3/31/2008

SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has begun a pivotal U.S. clinical trial of its investigational APTIMA(R) assay to detect human papillomavirus (HPV), which causes cervical cancer.

"Starting this highly complex, multi-center study was an important goal for Gen-Probe in early 2008," said Carl Hull, the Company's president and chief operating officer. "Enrolling our first patient last week is a testament to the hard work of our integrated product development team. We expect that their extensive efforts to date will ultimately result in the introduction of a highly accurate APTIMA HPV assay that improves the detection and treatment of cervical cancer."

The investigational APTIMA HPV assay is an amplified nucleic acid test that detects 14 high-risk HPV types that are associated with cervical cancer. More specifically, the assay detects two messenger RNAs (mRNAs), E6 and E7, that are made in higher amounts when HPV infections progress toward cervical cancer. Gen-Probe believes that targeting these mRNAs may more accurately identify women at higher risk of having, or developing, cervical cancer than competing assays that target HPV DNA. Detecting HPV DNA identifies women who are infected, but HPV infections are common and many resolve without causing cervical cancer.

Women undergoing routine Pap testing at participating U.S. clinics are eligible to participate in the clinical study, which includes two arms. One arm enrolls women whose Pap results are classified as ASC-US (atypical squamous cells of undetermined significance), meaning they are neither normal nor clearly indicative of changes associated with progression to cervical cancer. In t
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
8. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Colo. , July 27, 2015 /PRNewswire/ ... report financial results for the fourth quarter ... hold a conference call to discuss those ... Squarer, Chief Executive Officer will lead the ... a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 ...
(Date:7/27/2015)... 27, 2015 As per the new ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 ... billion in 2014, growing at a CAGR of 13.2% from ... 2021. The global bionics market is growing primarily ... is leading to paralysis or amputation of body parts. In ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has ... in Asia/Pacific Markets Seminar" conference to their offering. ... market is well established, the next growth area is ... , together with other countries in this region have ... their own medical device regulations. This seminar will provide ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... completed a clinical safety report from a large Phase ... the excellent,safety profile of IMVAMUNE(R). Within the next few ... to the FDA and this will trigger a USD ... safety,report constitutes a major part of the data package ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R) 2
(Date:7/28/2015)... ... 2015 , ... Women fear developing Alzheimer's disease more than having a heart ... stroke are treatable, but there is little an individual can do to arrest the ... a clinical trial, reports the July 2015 Harvard Women's Health Watch . , ...
(Date:7/28/2015)... ... , ... A new study published by HealthDay News on June 24, 2015, ... a possible new treatment option for people living with fibromyalgia – hyperbaric oxygen therapy ... five per week, patients experienced a significant decrease in pain, fatigue, and other symptoms ...
(Date:7/28/2015)... IN (PRWEB) , ... July 28, 2015 , ... Most ... released from the 2014 UBA Health Plan Survey shows a significant increase in the ... major increases in corresponding median copays -- a trend that is expected to continue, ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys ... the regional winner of the EY Entrepreneur of the Year award. The award ... of home healthcare, and the innovative work they have done in incorporating new ...
(Date:7/28/2015)... Maryland (PRWEB) , ... July 28, 2015 , ... Maryland ... (MBSP) – and, along with it, more service offerings, updated treatment techniques, and ... leading authority for pain management and minimally invasive surgical treatment of brain and spine ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4
... discover gender differences that explain the aging inequity ... discovered yet another gender inequity: Women develop more and ... men do. , The disadvantage had long been suspected, ... Dr. Foad Nahai, a plastic surgeon practicing in Atlanta ...
... , , GAINESVILLE, Fla., Dec. 17 Over the last ... scare language that is used by e cigarette opposition in an ... questioning the tactics of these groups when the evidence clearly shows ... to several studies, lab reports and opinions from top medial and ...
... , , HOUSTON, ... Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin ... for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic ... late-stage development - the rights to which have been ...
... ... the nearly one-in-three American adults who serve as a family caregiver , ... Arlington, VA (PRWEB) December 17, 2009 -- The ... 2009 , which offers a revealing portrait of the nearly one-in-three American adults who serve ...
... ... Google Local and in front of their local customers by establishing a simple and ... Internet Marketing. , ... New Orleans, LA (PRWEB) December 17, 2009 -- In order to be competitive locally ...
... , ... Using new marketing techniques, life coaching company puts free i-phone & i-touch application ... , ... (PRWEB) December 17, 2009 -- Utah based Attainment Life Management & Coaching is ...
Cached Medicine News:Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: